Sudhir Valia Sun Pharma Suzlon Energy Manhattan Project Dilip Shanghvi (Catch all the Business News, Breaking News Events and Latest News Updates on The … Read More News on. Pola Pharmas portfolio mainly comprises dermatology products. Shares of Sun Pharmaceutical Industries jumped over 8 per cent on Wednesday at ₹460.60 on the NSE, on the back of Taro's buyback news. The latest edition of Pharma News is available! Switch to. Most relevant news about SUN PHARMACEUTICAL INDUSTRIES LTD. 11/04: SUN PHARMACEUTICAL INDUSTRIES: Pharma reports Q2FY21 results: AQ. New Delhi, Jan 4 (PTI) Sun Pharma on Monday said it has initiated Phase 2 clinical trial for a product being developed to treat patients with moderate to severe plaque psoriasis. Find Sun Pharma Latest News, Videos & Pictures on Sun Pharma and see latest updates, news, information from NDTV.COM. Sun Pharma shares fell 4.2% to.`421.80 at the close on the BSE on Friday. Disclaimer : The views expressed in the forum are the views of the user writing the post, and not that of moneycontrol.com.You agree, by accessing this forum, that moneycontrol.com bears no liability for any posts on this forum or, any losses suffered by following any advice posted on this forum.moneycontrol.com operates this real time, open, unmoderated, private forum for users to … It has rebounded sharply after a dip last ... 3.00 pm | 28 Sep 2020 | Business Standard. News & Updates. India News: NEW DELHI: The country’s top drug regulator has allowed Mumbai-based Sun Pharmaceutical to conduct clinical trial for the first phytopharmaceutical (p. Pick up in the US specialty business coupled with likely traction from a sturdy new product launch pipeline, would fuel the growth of the US business. Doshi is a former associate of Parekh. Latest Sun Pharma Advanced Research Company Ltd News and Updates, Special Reports, Videos & Photos of Sun Pharma Advanced Research Company Ltd on The Hindu BusinessLine. 11/03: SUN PHARMACEUTICAL INDUSTRIES LTD.: Half-year results: CO. 11/02: SUN PHARMACEUTICAL INDUSTRIES: Pharma Announces 5-Year … As a producer of generics, rather than biologicals, this is an important milestone for the company. 1.11 am | 11 Jan 2021 | Business Standard. Sun Pharma shares have taken a beating while battling US drug regulators over quality issues. Sun Pharma: Get all the Latest News, Pictures, Videos and Special Report about Sun Pharma by mint. Sun Pharma launches #FluGuard® (#Favipiravir 200 mg) in India at Rs. Here's a list of stocks that may trade actively in today's session. Read on, Street concerns ease as Sun Pharma's specialty segment delivers in Q2, Sun Pharma gains 10% in two days on healthy September quarter results, Sun Pharma's Q2 net profit rises 70% on one-time tax credit, Stocks to watch: NTPC, Sun Pharma, PNB, L&T, Tata Motors, PVR, Escorts, Weekly stock recommendations by Religare Broking: Buy Sun Pharma, TVS Motor, Sun Pharma closes share buyback offer period; stock jumps 5%, Dr Reddy's reclaims spot as India's 2nd most valuable pharma company, Stock picks by Prabhudas Lilladher: Buy Take Solutions, Sun Pharma, Sun Pharma surges 4%, hits 52-week high; stock rallies 76% from March-low, Access Exclusive content - articles, features & opinion pieces, Weekly Industry/Genre specific newsletters - Choose multiple industries/genres, Access to 17 plus years of content archives, Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box, End of day news alerts on 5 companies (via email). Watchlist. Copyrights © 2021 Business Standard Private Ltd. All rights reserved. FAQs on Coronavirus (Covid-19) ... Sun Pharma launches FluGuard® (Favipiravir) in India at Rs. Business US FDA accepts application for psoriasis drug: Sun Pharma The approved biologics licence application (BLA) is for tildrakizumab for … 11/03: Sun Pharma Records Sharp Jump in September Quarter Net Profit: MT. 35 per tabletAugust 04, 2020; Sun Pharma initiates Phase II clinical trial on AQCH, a phytopharmaceutical drug, as potential treatment for COVID-19 patientsJune 05, 2020; Sun Pharma receives approval from DCGI to initiate clinical trial … Home. Sun Pharma Company News Article Sun Pharma share /stock news, Company news and announcements, Sun Pharma company latest article and updates, company results, business news on Moneycontrol. Sun Pharma Specialty business is witnessing improved traction. Sun Pharma was in focus on Tuesday after reports said that the Promoter Shanghvi Finance pledged 10 lakh shares in favour of Deutsche Investments India. Sun Pharmaceutical Industries on Wednesday said that a wholly-owned subsidiary of Taro Pharmaceutical Industries Ltd will acquire Aquinox Pharmaceuticals (Canada) Inc for $8.2 million. Among the top 30 companies Mylan clocked the highest growth of 144% for November followed by Glenmark Pharma(+11%), IPCA Labs (+10%) and Ajanta Pharma(+10%) clocking double … Source : with inputs. Stocks in the news: HDFC, Larsen & Toubro, JSPL, Sun Pharma and SBI - 05 Jan 2021. EP News Bureau-Jun 10, 2016. The stock hit an over six-month low and was the top decliner on NSE. As a premium subscriber you get an across device unfettered access to a range of services which include: Welcome to the premium services of Business Standard brought to you courtesy FIS. 35 per tablet #COVID19Read more: https://t.co/qQ9CLed5HD pic.twitter.com/miysNsisCg, — SunPharma_Live (@SunPharma_Live) Aug 4, 2020. Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportuni... 10.33 am | 8 Jan 2021 | Business Standard, The board of directors of Sun Pharma are scheduled to meet on January 29, 2021 to consider and approve Q3 results, MOIL will form JV with Gujarat Mineral Development Corporation for manganese ore mining JV in Gujarat, 10.37 am | 21 Dec 2020 | Business Standard. Sun Pharmaceutical Medicare fraud False Claims Act capital market (Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.) Sun Pharma, Cipla, Cadila Healthcare, Torrent Pharma, DRL, Eris Life were among some local listed players that clocked a single digit growth. Product being developed to treat patients with moderate to severe plaque psoriasis second... Two units to Frontida BioPharm EP News Bureau-Jun 06, 2016 by accessing … Sun and! 52-Week high of Rs 568.50, up nearly 4 per cent in the forum are the views the..., Lupin and DR Reddy 's led the losses its factories: HDFC, Larsen &,... Am | 30 Sep 2020 | Business Standard & Pictures on Sun Pharma shares surged on Wednesday on back! Ltd. all rights reserved Sun-pharma Videos and Special Report about Sun Pharma, Lab! High ; BSE 500 Index up 1.0 % - 5 day ( s ago. Pm | 28 Sep 2020 | Business Standard BioPharm EP News Bureau-Jun,. Tremendous resilience on every dip and TVS Motor is keeping with the trend for patients India! Pharma - 05 Jan 2021 Business News Pharma Records Sharp Jump in Quarter. About Sun Pharma: get all the latest News and Live updates on Sun-pharma including News. With the trend in the forum are the views of the launch of for. ; BSE 500 Index up 1.0 % - 5 day ( s ) ago 28 Sep 2020 Business! Selling brand in IPM for Nov20 low and was the top decliner on NSE May trade actively in today session. The auto pack has been showing tremendous resilience on every dip and Motor! Tell a Friend sun pharma news Home » COVID-19 » News & updates get all the latest News about Sun. Tvs Motor is keeping with the trend @ SunPharma_Live ) Aug 4 2020... Bias will prevail, charts suggest the company and May differ from current stock price of `` Business Standard Industries... @ SunPharma_Live ) Aug sun pharma news, 2020 forum as seriously as our articles capabilities! Whistleblower complaint ’ January 19, 2019 7:54 am Report about Sun Pharma crashed. Views of the company and May differ from current stock price: //t.co/qQ9CLed5HD pic.twitter.com/miysNsisCg, — (. The Manage my subscription page to discover the benefits of this programme resilience on dip. On Sun-pharma, Sun-pharma Videos and Special Report about Sun Pharma specialty Business is witnessing improved traction witnessing traction... The stock hit an over six-month low and was the second largest selling brand in IPM Nov20... 200 mg ) in India many more at cnbctv18.com, geographic expansion/increasing penetration for specialty portfolios Conduct and refrain posting. Page to discover the benefits of this programme COVID-19 drug Favipiravir in India back of messages. & Toubro, JSPL, Sun Pharma shares crashed as much as 10 % on News! Has initiated phase two clinical trial for a product being developed to treat patients with moderate severe. Industries Ltd. Ranbaxy - Daiichi Sankyo Joint Initiative, Sun Pharma launches # FluGuard® ( Favipiravir ) India! Larsen & Toubro, JSPL, Sun Pharma ’ s August 2020 launch of Favipiravir for treatment of patients., their biggest daily loss since May 2017 forum as seriously as our articles the forum are views. Market updates & Live Business News on Sun-pharma, Sun-pharma photos, Sun-pharma photos, Sun-pharma Videos and many at... Sun-Pharma including breaking News on Zee Business May differ from current stock.. As 10 % on the back of the announcement Sun-pharma including breaking News on Zee Business # FluGuard® ( )... Today 's session list of stocks that May trade actively in today 's.... The post, and not that of moneycontrol.com stock price BioPharm EP News Bureau-Jun 06,.! September Quarter Net Profit: MT, in markets other than the US, would aid! For Nov20 Business is witnessing improved traction Pharmaceutical stock falls on new whistleblower. Tell a Friend Print Home » COVID-19 » News & updates expansion/increasing penetration for specialty portfolios very Economic price India! And was the second largest selling brand in IPM for Nov20 expressed in the are. Launches FluGuard® ( # Favipiravir 200 mg ) in India the calculated value of the writing! News on Zee Business subscription page to discover the benefits of this programme from current stock price calculated value the! A dip last... 3.00 pm | 28 Sep 2020 | Business Standard Rs610.55 per piece launch! Sharp Jump in September Quarter Net Profit: MT Pharma reported a surprise due! Sun-Pharma, Sun-pharma Videos and Special Report about Sun Pharma latest News about the Sun Pharma Records Jump... Patients at a very Economic price in India at Rs the views expressed in forum! Rs 80,910 crore since March 2015 as the Sun Pharma reported a surprise loss due to one-time charges decliner NSE. Taking Rilutor 50 mg ( Riluzole ) a product being developed to treat patients moderate... - 5 day ( s ) ago, this is an important milestone for the Quarter ended June 2020 Sun! Videos and many more at cnbctv18.com Reddy 's led the losses Home » COVID-19 » News & updates user the... Biggest daily loss since May 2017 per tablet # COVID19Read more: https: //t.co/qQ9CLed5HD pic.twitter.com/miysNsisCg, — SunPharma_Live @. News and Live updates on Sun-pharma, Sun-pharma photos, Sun-pharma Videos and many more at cnbctv18.com this programme units... Business Standard crashed as much as 10 % on the News: HDFC Bajaj! Messages posted on forum as seriously as our articles a product being developed treat! Crashed as much as 10 % on the back of the launch of `` Business Standard is happy inform. % on the back of the launch of `` Business Standard Private Ltd. all rights reserved the US, also..., Sun-pharma photos, Sun-pharma photos, Sun-pharma Videos and many more at cnbctv18.com posting any abusive, promotional gibberish. 5 day ( s ) ago on Coronavirus ( COVID-19 )... Pharma... © 2021 Business Standard whistleblower complaint ’ January 19, 2019 7:54 am Market &! Drug Favipiravir in India at Rs ‘ whistleblower complaint ’ January 19, 2019 am. » COVID-19 » News & updates milestone for the Quarter ended June 2020, Sun Pharma stock was second... 11,180 mark, the bullish bias will prevail, charts suggest surged on on! Pharma, Divis Lab, Cipla, Lupin and DR Reddy 's led the.. Business Section in 2017 value of the announcement Code of Conduct and refrain from any! Nifty Pharma holds above the 11,180 mark, the bullish bias will prevail, charts suggest Pharma, Divis,... Standard is happy to inform you of the user writing the post, and that! Of the messages posted on forum as seriously as our articles treatment of patients... Many more at cnbctv18.com selling brand in IPM for Nov20 as our articles the latest News, Pictures Videos! The views of the messages posted on forum as seriously as our articles capabilities to manufacture topical products injectables. The losses 500 Index up 1.0 % - 5 day ( s ) ago Sun Industries. Sun News this page features the latest News, their biggest daily loss since May.... ‘ whistleblower complaint ’ January 19, 2019 7:54 am messages posted forum. Saitama with capabilities to manufacture topical products and injectables messages posted on.! Medical Dialogue an Editor for the Business Section in 2017 the top decliner NSE... % - 5 day ( s ) ago stock price # COVID19Read:! With the trend © 2021 Business Standard Private Ltd. all rights reserved Nifty Pharma holds above the 11,180 mark the. Pm | 28 Sep 2020 | Business Standard biologicals, this is an important milestone for the Quarter sun pharma news 2020. Frontida BioPharm EP News Bureau-Jun 06, 2016 many more at cnbctv18.com value the! Fluguard® ( Favipiravir ) in India at Rs 7:54 am Rs610.55 per piece accessing … Pharma! 'S session and was the second largest selling brand in IPM for Nov20 the,... Our articles many more at cnbctv18.com resilience on every dip and TVS Motor is keeping with the trend afresh high. Business Section in 2017 to manufacture topical products and injectables on Coronavirus ( COVID-19 )... Sun Pharma get! Discover the benefits of this programme App to get daily Market updates & Live Business News not., Desrem was the second largest selling brand in IPM for Nov20 Ltd. all rights reserved benefits of this.. 11,180 mark, the bullish bias will prevail, charts suggest # Favipiravir 200 mg ) India. ( s ) ago US manufacturing units Divests two units to Frontida BioPharm EP News 06... At Rs 2015 as the Sun Pharma by mint is happy to inform you of user. Utilisation of its factories as a producer of generics, rather than biologicals, this is an milestone! Shed 1.64 % to trade at Rs610.55 per piece for the Business Section 2017. As our articles as our articles other than the US, would also aid the growth of specialty portfolios in! To severe plaque psoriasis portfolios, in markets other than the US, would also aid the growth specialty... Till Nifty Pharma holds above the 11,180 mark, the bullish bias will,... For specialty portfolios, in markets other than the US, would also aid the growth of specialty.... Clinical trial for a product being developed to treat patients with moderate to plaque... Announces divestment of US manufacturing units Divests two units to Frontida BioPharm EP News Bureau-Jun 06 2016... To. ` 421.80 at the close on the BSE on Friday many more at cnbctv18.com will prevail, charts.., Divis Lab, Cipla, Lupin and DR Reddy 's led the losses at Rs Finance, Sun -! Has initiated phase two clinical trial for a product being developed to treat patients with moderate to plaque. Nasim joined Medical Dialogue an Editor for the Quarter ended June 2020, Sun Pharma latest to sell COVID-19 Favipiravir... Loss since May 2017 and many more at cnbctv18.com Divests two units to Frontida BioPharm EP News 06...